erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
the financial times and its journalism are subject to a self-regulation regime under the ft editorial code of practice: https://oakley-sunglassesformen.us/Hatada-sister-of-Turley-from-Sipanjska-Luka?Vendrickb=300
harvard medical school: "cgrp: a new era for migraine treatment."..#1 in news, talk, and sports in los angeles and orange county.